Serious Side Effects (Rare) Serious adverse events were reported in 4.8% and 3.5% of participants respectively One case of adjudication-confirmed pancreatitis was reported (in the semaglutide group) No deaths occurred in either treatment group No cases of medullary thyroid cancer or pancreatic cancer were reported When to Contact Your Doctor Seek medical attention if you experience: Severe or persistent abdominal pain (possible sign of pancreatitis) Signs of an allergic reaction (rash, swelling, difficulty breathing) Symptoms of low blood sugar (shakiness, dizziness, confusion) Persistent vomiting or inability to keep fluids down Any new or worsening symptoms Horizontal bar chart comparing common side effects of tirzepatide and semaglutide including nausea constipation diarrhoea and vomiting from SURMOUNT-5 trial data Tips for Getting the Most from Your Treatment The medication works alongside, not instead of, healthy lifestyle habits
A once-weekly dual GLP-1 and GIP receptor agonist, compounded and prescribed to work on two metabolic pathways at once for the right candidate
EA, on the basis of traditional acupuncture, can enhance the intensity and duration of acupuncture by stimulating acupoints with electric current
It's used as part of a structured, clinician-guided weight loss plan
Body composition and muscle preservation for women on retatrutide Why muscle matters more than the number on the scale Weight loss and fat loss are not the same thing
